Prevalence of dental alterations in patients under bisphosphonates therapy: a systematic review
- PMID: 35661941
- DOI: 10.1007/s10006-022-01084-9
Prevalence of dental alterations in patients under bisphosphonates therapy: a systematic review
Abstract
This systematic review aimed to estimate the prevalence and describe dentoalveolar lesions associated with bisphosphonates therapy. A systematic review of the literature was conducted using the following databases: PubMed, Embase, Cochrane, CINAHL, Scopus, Web of Science, Lilacs, SciElo, and Grey Literature. Quality of individual studies analysis was performed by using Newcastle-Ottawa Scale. Certainty of cumulative evidence was achieved by applying Grading of Recommendations Assessment, Development, and Evaluation (GRADE) criteria. The software R Statistics version 4.0.5 (The R Foundation) was used for proportion estimations per study and corresponding confidence intervals were estimated through the Clopper-Pearson method. Four articles were included for the qualitative synthesis. Two studies were considered of good quality, one of fair, and one of poor quality. A total of 231 patients were encompassed. Widening of the periodontal ligament space (22.2-39.7%), periradicular radiolucencies (20-22.9%), and pulp calcifications (33.3-69.2%) were the most frequent alterations. Certainty of evidence was rated as very low. Based on limited evidence, this systematic review reports a variety of dentoalveolar alterations in patients under bisphosphonate therapy. These features might impact on dental clinical practice. However, the level of evidence is considered very low due to important limitations.
Keywords: Bisphosphonates; Evidence-based dentistry; Systematic review; Teeth.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Rodan GA, Fleisch HA (1996) Bisphosphonates: mechanisms of action. J Clin Invest 97:2692–2696. https://doi.org/10.1172/JCI118722 - DOI - PubMed - PMC
-
- Russell RGG, Watts NB, Ebetino FH, Rogers MJ (2008) Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int 19:733–759. https://doi.org/10.1007/s00198-007-0540-8 - DOI - PubMed
-
- Kuźnik A, Październiok-Holewa A, Jewula P, Kuźnik N (2020) Bisphosphonates—much more than only drugs for bone diseases. Eur J Pharmacol 866:. https://doi.org/10.1016/j.ejphar.2019.172773
-
- Clézardin P, Gligorov J, Delmas P (2000) Mechanisms of action of bisphosphonates on tumor cells and prospects for use in the treatment of malignant osteolysis. Joint Bone Spine 67:22–29 - PubMed
-
- Soares AP, do Espírito Santo RF, Line SRP et al (2016) Bisphosphonates: pharmacokinetics, bioavailability, mechanisms of action, clinical applications in children, and effects on tooth development. Environ Toxicol Pharmacol 42:212–217. https://doi.org/10.1016/j.etap.2016.01.015 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
